Company Focus

Novo Nordisk

Latest Novo Nordisk News

The week in pharma: action, reaction and insight – week to November 8
Pharmaceutical
Research results featured heavily in the news last week, first with Viking Therapeutics releasing promising early-stage data for its investigational medicine VK2738 at the ObesityWeek meeting. US biotech Beam Therapeutics released early-stage data on its sickle cell disease candidate BEAM-101. Also of note, Arcus Biosciences and Gilead Sciences announced promising Phase III results for their TIGIT inhibitor domvanalimab in combination with zimberelimab. Denmark’s Novo Nordisk released financial results that attracted interest.   10 November 2024


Insights

Company Spotlight

Latest News & Features of interest to Novo Nordisk

Latest Related Ones To Watch News

European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent.   5 November 2024

More in M&A >


Related Ones to Watch Companies

Reset all filters
Refine Search